Features Partner Sites Information LinkXpress
Sign In
Demo Company

New Pipetting Workstation Automates PCR Routines

By BiotechDaily International staff writers
Posted on 05 Feb 2014
Print article
Image: The NIMBUS PCR Workstation (Photo courtesy of the Hamilton Robotics Company).
Image: The NIMBUS PCR Workstation (Photo courtesy of the Hamilton Robotics Company).
Biotechnology laboratories that regularly process PCR samples will be certain to benefit from a new pipetting workstation.

Hamilton Robotics (Reno, NV, USA) has introduced the NIMBUS PCR Workstation, which is a compact and affordable pipetting workstation enabling fast and flexible assay setup for endpoint, real-time, qPCR, or multiplex PCR.

The workstation offers a high-density deck layout with a compact laboratory bench footprint. The instrument boasts a dynamic pipetting range from 1 to 1,000 microliters. The system utilizes the same high speed pipetting head as Hamilton's more expensive line of STAR instruments.

The workstation incorporates an easy-to-use software wizard that suits a wide range of applications including gene expression, genotyping, sequencing, and pathogen detection. Furthermore, the NIMBUS PCR Workstation accommodates a variety of tip and labware types.

The onboard INSTINCT PCR wizard utilizes a graphical interface to guide users through processing gene and sample combinations. The software traces all input components, completes setup information throughout the process, and saves all data for future use. In addition, the software wizard has a flexible PCR plate-designing tool for maximum convenience and displays real-time three-dimensional deck configurations.

Related Links:

Hamilton Robotics

Print article



view channel
Image: Left: Green actin fibers create architecture of the cell. Right: With cytochalasin D added, actin fibers disband and reform in the nuclei (Photo courtesy of the University of North Carolina).

Actin in the Nucleus Triggers a Process That Directs Stem Cells to Mature into Bone

A team of cell biologists has discovered why treatment of mesenchymal stem cells (MSCs) with the mycotoxin cytochalasin D directs them to mature into bone cells (osteoblasts) rather than into fat cells... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.